Have you been diagnosed with B-cell post-transplant lymphoproliferative disorder (PTLD) after an organ transplant? Have you not yet received any type of treatment for this condition? Then you may be eligible for a study to look at the safety and effectiveness of tafasitamab and rituximab combination treatment for PTLD.

Are you someone living with Parkinson's disease? If so, you are aware that in addition to symptoms affecting movement, people with Parkinson's disease also experience non-motor symptoms such as problems with mood and motivation which can be difficult to treat. If you have been living with Parkinson's disease for at least 4 years and take medication for Parkinson's disease, you may be eligible to participate in a research study aimed at treating low motivation with a form of non-invasive brain stimulation called transcranial magnetic stimulation (TMS).

Do you have untreated Acute Lymphoblastic Leukemia (ALL) and/or you have relapsed or refractory ALL? You may be able to take part in a research study to help us learn more about the effects of a combination of two drugs on your leukemia.

The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific genetic mutation (KRAS G12C). Patients must have already received or were not able to tolerate the standard of care, except for specific groups who have not had cancer treatment.

This study is designed to determine whether our voice-based recall system can recall your food from the past 24 hours in comparison to the ASA-24 web based method.

The purpose of this research study is to explore common experiences related to forming stepfamily relationships (and it's completely okay if you do not identify as a "stepfamily").

The purpose of this study is to learn if the Fitlight Vision Board can measure how fast you can respond to a series of lights.

Do you have a new diagnosis of Acute Myeloid Leukemia and are looking for another treatment option? In this study, we are looking to see if the study drug (Tagraxofusp) can help control Leukemia or achieve remission.

The purpose of this research is to understand how the combination of augmented reality technology and natural language commands can support anyone with programming a robot to perform a task. As robots enter our world, everyday users will need to tell a robot what to do, like an Amazon Alexa or Google Home. With today's robots, this is not possible. That is why we need your help!

Examine the validity and reliability of UTRS in the assessment of essential tremor (ET) and Parkinson tremor.